| 101 | Arista Networks Inc | 12 936 | 1,6 M $ | |
| 102 | Leidos Holdings Inc | 10 140 | 1,6 M $ | |
| 103 | LPL Financial Holdings Inc | 5 198 | 1,6 M $ | |
| 104 | Micron Technology Inc | 4 625 | 1,6 M $ | |
| 105 | HEICO Corp | 5 605 | 1,5 M $ | |
| 106 | IDEXX Laboratories Inc | 2 731 | 1,5 M $ | |
| 107 | S&P Global Inc | 3 603 | 1,5 M $ | |
| 108 | Advanced Micro Devices Inc | 7 529 | 1,5 M $ | |
| 109 | United Rentals Inc | 2 091 | 1,5 M $ | |
| 110 | Ulta Beauty Inc | 2 914 | 1,5 M $ | |
| 111 | Insulet Corp | 7 163 | 1,5 M $ | |
| 112 | Microsoft Corp | 3 948 | 1,5 M $ | |
| 113 | Moderna Inc | 28 656 | 1,5 M $ | |
| 114 | Amphenol Corp | 11 414 | 1,4 M $ | |
| 115 | MercadoLibre Inc | 827 | 1,4 M $ | |
| 116 | AppLovin Corp | 3 491 | 1,4 M $ | |
| 117 | Cognizant Technology Solutions Corp. | 22 418 | 1,4 M $ | |
| 118 | DoorDash Inc | 9 152 | 1,4 M $ | |
| 119 | Iovance Biotherapeutics Inc | 383 763 | 1,3 M $ | |
| 120 | Apellis Pharmaceuticals Inc | 33 462 | 1,3 M $ | |
| 121 | OFS CREDIT COMPANY INC | 462 155 | 1,3 M $ | |
| 122 | Axon Enterprise Inc | 3 109 | 1,3 M $ | |
| 123 | Robinhood Markets Inc | 18 033 | 1,2 M $ | |
| 124 | Carvana Co | 3 972 | 1,2 M $ | |
| 125 | Erasca Inc | 75 746 | 1,2 M $ | |
| 126 | Mirum Pharmaceuticals Inc | 12 987 | 1,2 M $ | |
| 127 | BioCryst Pharmaceuticals Inc | 111 529 | 1,1 M $ | |
| 128 | Agios Pharmaceuticals Inc | 30 959 | 1 M $ | |
| 129 | Novavax Inc | 128 505 | 1 M $ | |
| 130 | United Therapeutics Corp | 1 707 | 1 M $ | |
| 131 | KalVista Pharmaceuticals Inc | 49 927 | 1 M $ | |
| 132 | Syndax Pharmaceuticals Inc | 41 445 | 968,2 k $ | |
| 133 | Axsome Therapeutics Inc | 5 698 | 963,1 k $ | |
| 134 | XAI Octagon Floating | 55 758 | 957,9 k $ | |
| 135 | Geron Corp | 620 795 | 925 k $ | |
| 136 | TG Therapeutics Inc | 26 930 | 894,6 k $ | |
| 137 | BioMarin Pharmaceutical Inc | 15 836 | 894,6 k $ | |
| 138 | ZAI LAB LTD | 47 511 | 893,7 k $ | |
| 139 | BLACKROCK TCP CAPITAL CORP | 247 315 | 892,8 k $ | |
| 140 | Krystal Biotech Inc | 3 449 | 890,9 k $ | |
| 141 | Ligand Pharmaceuticals Inc | 4 453 | 889 k $ | |
| 142 | Biogen Inc | 4 848 | 888,8 k $ | |
| 143 | Exelixis Inc | 20 651 | 885,7 k $ | |
| 144 | Prospect Capital Corp | 337 946 | 882 k $ | |
| 145 | Halozyme Therapeutics Inc | 13 571 | 877,1 k $ | |
| 146 | Ascendis Pharma A/S | 3 830 | 876 k $ | |
| 147 | Sarepta Therapeutics Inc | 39 213 | 853,3 k $ | |
| 148 | Bridgebio Pharma Inc | 11 234 | 834,2 k $ | |
| 149 | Ardelyx Inc | 135 954 | 814,4 k $ | |
| 150 | BioNTech SE | 8 904 | 791,4 k $ | |
| 151 | Goldman Sachs BDC, Inc. | 88 738 | 788 k $ | |
| 152 | BEONE MEDICINES LTD | 2 646 | 785,8 k $ | |
| 153 | Ionis Pharmaceuticals Inc | 10 445 | 784,3 k $ | |
| 154 | Madrigal Pharmaceuticals Inc | 1 476 | 772,6 k $ | |
| 155 | PTC Therapeutics Inc | 11 160 | 760,3 k $ | |
| 156 | Arrowhead Pharmaceuticals Inc | 12 045 | 755,2 k $ | |
| 157 | PENNANTPARK INVESTMENT CORPORATION | 165 540 | 743,3 k $ | |
| 158 | FS KKR Capital Corp | 72 227 | 735,3 k $ | |
| 159 | Oaktree Specialty Lending Corp | 64 582 | 729,8 k $ | |
| 160 | Tarsus Pharmaceuticals Inc | 10 378 | 728 k $ | |
| 161 | Neurocrine Biosciences Inc | 5 524 | 727,7 k $ | |
| 162 | Travere Therapeutics Inc | 24 239 | 720,1 k $ | |
| 163 | Insmed Inc | 4 283 | 700,4 k $ | |
| 164 | New Mountain Finance Corp | 89 471 | 694,3 k $ | |
| 165 | ACADIA Pharmaceuticals Inc | 31 095 | 692,2 k $ | |
| 166 | Immunocore Holdings PLC | 22 940 | 691,6 k $ | |
| 167 | Arcutis Biotherapeutics Inc | 29 092 | 685,4 k $ | |
| 168 | LEGEND BIOTECH CORP | 37 824 | 684,2 k $ | |
| 169 | Kura Oncology Inc | 82 610 | 671,6 k $ | |
| 170 | RUNWAY GROWTH FINANCE CORP. | 96 849 | 665,4 k $ | |
| 171 | Invesco Senior Income Trust | 203 173 | 654,2 k $ | |
| 172 | Rhythm Pharmaceuticals Inc | 7 434 | 646,5 k $ | |
| 173 | Phathom Pharmaceuticals Inc | 57 986 | 644,2 k $ | |
| 174 | Enliven Therapeutics Inc | 16 173 | 634 k $ | |
| 175 | MidCap Financial Investment Corp | 55 212 | 620,6 k $ | |
| 176 | GOLUB CAPITAL BDC INC | 48 365 | 612,3 k $ | |
| 177 | CION Investment Corp. | 89 408 | 611,6 k $ | |
| 178 | Tango Therapeutics Inc | 29 163 | 610,1 k $ | |
| 179 | Carlyle Secured Lending Inc | 55 723 | 609,6 k $ | |
| 180 | Crinetics Pharmaceuticals Inc | 16 721 | 607,3 k $ | |
| 181 | HORIZON TECHNOLOGY FINANCE CORP | 143 968 | 606,1 k $ | |
| 182 | PennantPark Floating Rate Capi | 75 014 | 603,1 k $ | |
| 183 | SOUND POINT MERIDIAN CAPITAL INC | 67 142 | 600,9 k $ | |
| 184 | Esperion Therapeutics Inc | 219 293 | 600,9 k $ | |
| 185 | Harmony Biosciences Holdings Inc | 20 840 | 583,7 k $ | |
| 186 | Gladstone Investment Corp | 41 033 | 582,7 k $ | |
| 187 | SARATOGA INVESTMENT CORP | 25 752 | 563,2 k $ | |
| 188 | Blackstone Secured Lending Fund | 23 703 | 561,5 k $ | |
| 189 | Nuveen Floating Rate Income Fund | 74 365 | 559,2 k $ | |
| 190 | STELLUS CAPITAL INVESTMENT CORP | 60 672 | 558,8 k $ | |
| 191 | BlackRock Technology & Private Equity Term Trust | 84 306 | 556,4 k $ | |
| 192 | Nuveen Credit Strategies Income Fund | 113 677 | 553,6 k $ | |
| 193 | CRESCENT CAPITAL BDC INC | 44 918 | 545,8 k $ | |
| 194 | Dianthus Therapeutics Inc | 6 472 | 543,1 k $ | |
| 195 | BlackRock Floating Rate Income Trust | 50 319 | 541,4 k $ | |
| 196 | KKR Income Opportunities Fund | 48 573 | 534,3 k $ | |
| 197 | FIDUS INVESTMENT CORP | 30 443 | 530,3 k $ | |
| 198 | Bain Capital Specialty Finance Inc | 42 488 | 526,9 k $ | |
| 199 | Alumis Inc | 23 732 | 522,8 k $ | |
| 200 | Hercules Capital Inc | 34 656 | 511,9 k $ | |